We first tested the effect of NSC185058, which targets ATG4b (Fig. 8k).53 Treatment with NSC185058 or irradiation alone decreased IDH1 glioma cells viability compared to vehicle (Figs. 8l–n). The gene discussed is IDH1; the disease is glioma.